Women with multiple sclerosis, particularly after menopause, experience a higher risk of relapse-independent worsening, ...

Scientists have identified an unusual type of brain cell that may play a vital role in progressive multiple sclerosis (MS), ...

Researchers have identified a rare type of brain cell that may drive the chronic inflammation and neurodegeneration seen in progressive multiple sclerosis (MS).

Broad rim lesions have been identified as a new biomarker for rapid multiple sclerosis progression, offering key insights ...

Menopause does not worsen disability progression in women with multiple sclerosis, according to the largest study of its kind ...

Vidofludimus calcium currently is being evaluated in relapsing MS in two phase III trials, ENSURE-1 and ENSURE-2. The phase ...

FRIDAY, Oct. 3, 2025 (HealthDay News) — Menopause does not increase symptoms and disability among women with multiple ...

Already approved for progressive multiple sclerosis, ocrelizumab in a second phase 3 study demonstrates meaningful clinical ...

While Bruton’s tyrosine kinase inhibitors are often hailed as the next big breakthrough in multiple sclerosis, Immunic ...

A preclinical study by biomedical scientists at the University of California, Riverside, has shown why some people with ...

Bruce Bebo, executive vice president of research at the National MS Society, says NMSS investments are helping advance MS ...

Discover a new study showing that menopause does not accelerate disability in women with multiple sclerosis, offering ...